[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
Gaede
Peter Haulund
PH
Steno Diabetes Center, Amtssygehuset Roskilde, Kardiologisk Afdeling. peter.gaede@dadlnet.dk
Jepsen
Pernille Vedel
PV
Larsen
Jens Nicolai Brink
JN
Jensen
Gunnar Vagn
GV
Parving
Hans-Henrik
HH
Pedersen
Oluf Borbye
OB
D000671:Amputation, Surgical; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D003131:Combined Modality Therapy; D003920:Diabetes Mellitus / Q000178:diet therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy*; D018752:Diet, Fat-Restricted; D015444:Exercise; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D009765:Obesity; D012307:Risk Factors; D016540:Smoking Cessation; D020521:Stroke / Q000517:prevention & control; D014815:Vitamins / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D014815:Vitamins; D000804:Angiotensin II